Article
Monotherapy efficacy of BBB-permeable small molecule activators of PP2A in glioblastoma
2019-09-23
Abstract excerpt
Glioblastoma (GB) is a fatal disease in which most targeted therapies have clinically failed. However, pharmacological reactivation of tumor suppressors has not been thoroughly studied as yet as a GB therapeutic strategy. Tumor suppressor Protein Phosphatase 2A (PP2A), is inhibited by non-genetic mechanisms in GB, and thus it would be potentially amendable for therapeutic reactivation. Here we demonstrate, that s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8817e6a-1d24-5b0b-82f6-9bd1f5168899
- DOI
- 10.1101/777276
